EU medicines regulator says benefits of J&J vaccine outweigh risks as it reviews rare blood clots ...United Arab Emirates

CNBC - Economy
EU medicines regulator says benefits of J&J vaccine outweigh risks as it reviews rare blood clots
Europe's medicines regulator on Wednesday said it still believes the benefits of Johnson & Johnson's Covid-19 vaccine outweigh the risks of side effects.

Hence then, the article about eu medicines regulator says benefits of j j vaccine outweigh risks as it reviews rare blood clots was published today ( ) and is available on CNBC ( United Arab Emirates ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( EU medicines regulator says benefits of J&J vaccine outweigh risks as it reviews rare blood clots )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in Economy


Latest News
before 3 hours & 22 minute